We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$10.7B
1-Year Est. Return
67.78%
This Fund
S&P 500
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+67.78%
3 Year Est. Return
+183.84%
5 Year Est. Return
+266.8%
10 Year Est. Return
+1,486.88%
AUM
$13.7B
AUM Growth
+$435M
(+3.3%)
Cap. Flow
-$546M
Cap. Flow
% of AUM
-4%
Top 10 Holdings %
Top 10 Hldgs %
15.96%
Holding
301
New
25
Increased
112
Reduced
147
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NovoCure
NVCR
|
+$69.3M |
| 2 |
SGFY
Signify Health, Inc.
SGFY
|
+$62.1M |
| 3 |
Natera
NTRA
|
+$56.9M |
| 4 |
Leslie's
LESL
|
+$53.5M |
| 5 |
VMEO
Vimeo
VMEO
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$207M |
| 2 |
Magnite
MGNI
|
+$140M |
| 3 |
Caesars Entertainment
CZR
|
+$89.3M |
| 4 |
PPLI
People Inc
PPLI
|
+$84.5M |
| 5 |
Vulcan Materials
VMC
|
+$59.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.46% |
| 2 | Consumer Discretionary | 19.17% |
| 3 | Healthcare | 18.19% |
| 4 | Industrials | 15.16% |
| 5 | Financials | 12.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
101
DELISTED
Amedisys
AMED
| $50.9M | 0.37% |
207,883
-24,481
| -11% | -$6.42M |
|
102
Dana Inc
DAN
$3.26B
| $50.6M | 0.37% |
2,128,949
-893,468
| -30% | -$23.2M |
|
103
BioMarin Pharmaceuticals
BMRN
$12.9B
| $50.6M | 0.37% |
606,208
+25,296
| +4% | +$2.01M |
|
104
Acadia Healthcare
ACHC
$2.61B
| $50.3M | 0.37% |
802,255
-231,790
| -22% | -$14.5M |
|
105
Insight Enterprises
NSIT
$4.75B
| $50.3M | 0.37% |
502,728
-52,107
| -9% | -$5.27M |
|
106
Pacira BioSciences
PCRX
$984M
| $49.3M | 0.36% |
812,073
-226,302
| -22% | -$14.3M |
|
|
PDCE
107
DELISTED
PDC Energy, Inc.
PDCE
| $49.3M | 0.36% |
1,075,688
+45,973
| +4% | +$1.88M |
|
108
Workday
WDAY
$46.8B
| $49.1M | 0.36% |
205,571
+4,039
| +2% | +$971K |
|
109
Carvana
CVNA
$51B
| $48.6M | 0.36% |
805,950
-104,295
| -11% | -$5.67M |
|
110
Moody's
MCO
$82.8B
| $48.1M | 0.35% |
132,742
-17,081
| -11% | -$5.69M |
|
111
Sarepta Therapeutics
SRPT
$2.21B
| $47.9M | 0.35% |
+615,580
| New | +$46.7M |
|
112
Incyte
INCY
$24.8B
| $46.7M | 0.34% |
554,960
-71,708
| -11% | -$5.98M |
|
113
Evercore
EVR
$10.6B
| $45.8M | 0.34% |
325,240
+286
| +0.1% | +$40K |
|
114
HubSpot
HUBS
$12.5B
| $45.1M | 0.33% |
77,474
+76,649
| +9,291% | +$40M |
|
115
Alcon
ALC
$32.7B
| $44.9M | 0.33% |
639,385
-82,851
| -11% | -$5.9M |
|
116
Concentrix
CNXC
$1.79B
| $44.7M | 0.33% |
278,225
+4,517
| +2% | +$695K |
|
117
Guardant Health
GH
$22.5B
| $44.3M | 0.32% |
356,751
-45,590
| -11% | -$6.13M |
|
118
Domino's
DPZ
$10.7B
| $43.8M | 0.32% |
93,997
-11,331
| -11% | -$4.8M |
|
119
Dollar General
DG
$28.5B
| $43.4M | 0.32% |
200,647
-22,871
| -10% | -$4.81M |
|
120
MDU Resources
MDU
$3.94B
| $43M | 0.31% |
3,604,444
+63,138
| +2% | +$791K |
|
121
Leidos
LDOS
$16.7B
| $42.6M | 0.31% |
421,492
-54,664
| -11% | -$5.61M |
|
122
WaFd
WAFD
$2.49B
| $42.5M | 0.31% |
1,337,245
-1,425
| -0.1% | -$46.4K |
|
|
SGEN
123
DELISTED
Seagen Inc. Common Stock
SGEN
| $42.4M | 0.31% |
268,590
-33,790
| -11% | -$5.02M |
|
124
ATI
ATI
$25.6B
| $41.7M | 0.31% |
2,000,237
+1,013,330
| +103% | +$23.2M |
|
125
NCR Voyix
VYX
$1.14B
| $41.4M | 0.3% |
1,479,375
+155,843
| +12% | +$4.31M |
|
Similar funds
VAS
SIM
FMI
HL
RCMF
DPIM
CA
SCM
Frontier Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Frontier Capital Management held 301 positions worth $13.7B, up 3.3% from $13.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Frontier Capital Management withdrew a net $546M in Q2 2021, closing 17 positions and reducing 147 holdings. Its most notable exit was Magnite, an estimated $140M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Frontier Capital Management opened a new position in Signify Health, Inc. worth $68.7M.
- Frontier Capital Management's largest Q2 2021 buy was Signify Health, Inc.: 2,258,629 shares worth $68.7M.
- Frontier Capital Management added most to NovoCure in Q2 2021, an estimated $69.3M increase.
- Frontier Capital Management's biggest Q2 2021 reduction was Nuance Communications, Inc., cutting an estimated $207M.
- Frontier Capital Management fully exited Magnite in Q2 2021, selling an estimated $140M.
- Frontier Capital Management's ten largest holdings make up 16% of its $13.7B portfolio in Q2 2021.
- Frontier Capital Management opened 25 new positions and closed 17 in Q2 2021.
- Frontier Capital Management's portfolio value rose 3.3% quarter-over-quarter to $13.7B.
Based on Frontier Capital Management's 13F filing for Q2 2021, filed 9 Aug 2021.